Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2012
06/21/2012WO2012080221A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012080220A1 Novel compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012080115A1 Strigolactam derivatives and their use as plant growth regulators
06/21/2012WO2012043996A3 Compound in which amine derivative is substituted with fluorene, organic electronic device using same, and terminal thereof
06/21/2012WO2012027623A3 Cyanine dyes
06/21/2012WO2011161255A4 Processes for the resolution of nitrogen substituted (s) - 5 -alkoxy- 2 -aminotetralin derivatives
06/21/2012US20120157690 USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE
06/21/2012US20120157641 Cure accelerators for anaerobic curable compositions
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120156255 Drug eluting patch for the treatment of localized tissue disease or defect
06/21/2012US20120156140 Fluorescent compounds
06/21/2012US20120153815 Organic electroluminescence device
06/21/2012US20120153266 Fluorescent isoindoline dyes
06/21/2012CA2820934A1 Strigolactam derivatives and their use as plant growth regulators
06/21/2012CA2819171A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012CA2817365A1 Process and intermediates for preparing macrolactams
06/20/2012EP2464628A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
06/20/2012EP2464627A2 Phenanthro[1,10,9,8-c,d,e,f,g]carbazole polymers and their use as organic semiconductors
06/20/2012EP2464624A2 Pesticidal carboxamides
06/20/2012EP2464616A1 Organic compound and organic light-emitting device using the same
06/20/2012EP2464227A1 Compounds and methods of use thereof
06/20/2012EP1963276B1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/20/2012EP1960347B1 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
06/20/2012CN1659193B Polymerization catalyst activators, method of preparing and their use in polymerization processes
06/20/2012CN102504054A Hydroxy-ketone photoinitiator containing multiple functional groups for reducing and eliminating VOC (volatile organic compounds) emission
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102503884A Synthesis method of phenylphthalimide analog
06/20/2012CN102503883A Method for selectively preparing isoindoline-1-ketone derivative or isoquinoline-1-ketone derivative
06/20/2012CN102503882A Halogenated benzaldehyde indole Schiff base as well as preparation method and application thereof
06/20/2012CN102503881A Optically active tryptamine derivative and synthetic method and application thereof
06/20/2012CN102503850A Hydroxyl-contained N-acylamino acid and preparation method thereof
06/20/2012CN102503753A Method for synthesizing 2-amino five-membered heterocyclic derivative
06/20/2012CN102503747A Synthetic method of polyfluorinated aromatic hydrocarbon-hetero-aromatic ring building block
06/20/2012CN102040551B Synthesizing method of phthaloyl-beta-alanine
06/20/2012CN101679253B Process for purifying 2-phenyl-3, 3 -bis(4-hydroxyphenyl) phthalimidine (PPPBP)
06/20/2012CN101195600B Method for producing 4-hydroxyindole
06/20/2012CN101189318B Reversibly thermochromic compositions
06/19/2012US8203004 Tetrahydroindole derivatives for treatment of alzheimer's disease
06/19/2012US8202871 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/14/2012WO2012078519A2 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
06/14/2012WO2012078005A2 Compounds having hole conducting property, co-adsorbent body comprising same, and dye-sensitized solar cell comprising the co-adsorbent body
06/14/2012WO2012077520A1 Organic electroluminescent element
06/14/2012WO2012077431A1 Process for manufacture of organic electroluminescent element
06/14/2012WO2012077138A1 Methods of crystallizing (r) -1- (3 -hydroxypropyl) -5- [2- [2- [2- ( 2, 2, 2 - trifluoroethoxy) phenoxy] ethylamino] propyl] indoline-7 -carboxamide
06/14/2012WO2012034116A3 Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
06/14/2012US20120149915 Method for synthesis of n-alkyl carbazole and deriratives thereof
06/14/2012US20120149909 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120146264 Resin composition for laser engraving, relief printing plate precursor for laser engraving and process for producing same, and process for making relief printing plate
06/14/2012US20120146014 Aromatic amine derivatives and organic electroluminescent elements using same
06/13/2012EP2463275A1 Novel compounds and compositions thereof
06/13/2012EP2461683A1 Bicyclic aryl sphingosine 1-phosphate analogs
06/13/2012CN1352558B Immediate release medicinal compositions for oral use
06/13/2012CN102498098A Processes for the synthesis of (2s, 3ar, 7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril
06/13/2012CN102498097A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498096A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498095A Indoline derivatives
06/13/2012CN102491979A 1-hydroxyethyl-5-substituted indolone derivative and preparation method and application thereof
06/13/2012CN102491937A Preparation method of high-purity 3-bromine-N-phenylcarbazole
06/13/2012CN102491936A Conjugated compound with yellow-green fluorescence and preparation method and use thereof
06/13/2012CN102491935A Nitrobenzaldehyde indole schiff base, preparation method and application thereof
06/13/2012CN102491934A Hydroxyl and alkoxyl benzaldehyde indole Schiff bases, preparation method thereof, and application thereof
06/13/2012CN102491933A Substituted 5-acrylic acid indole dione derivative, as well as preparation method and application thereof
06/13/2012CN102491932A 3-indoline ketone derivative, and preparation method and application thereof
06/13/2012CN102491931A 3-substituted indolone derivative and preparation method and application thereof
06/13/2012CN102491930A Synthesizing method for pH fluorescent probe taking tricarbocyanine as matrix
06/13/2012CN101948420B Preparation method for separating and purifying tryptophan monomers from nitraria fruit juice
06/13/2012CN101914053B Method for preparing indolylacetic acid and abscisic acid from seaweeds
06/13/2012CN101646650B Sub-type selective azabicycloalkane derivatives
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198801 Materials for injecting or transporting holes and organic electroluminescence devices using the same
06/12/2012US8198463 Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.3.0]-hexane compounds and enantiomeric salts thereof
06/12/2012US8198462 Dendritic photoactive compound comprising oxime ester and method for preparing the same
06/12/2012US8198315 Therapeutic substituted cyclic lactams
06/12/2012US8198314 Treatment of CRTH2-mediated diseases and conditions
06/12/2012US8198313 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198274 Substituted indolyl and indazolyl derivatives and uses thereof
06/12/2012CA2658523C Inhibitors of plasma kallikrein
06/12/2012CA2560897C Macrocyclic compounds as inhibitors of viral replication
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/07/2012WO2012075473A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
06/07/2012WO2012073041A2 Compounds
06/07/2012US20120142940 Process For The Synthesis Of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicycle[3.1.0]Hexane
06/07/2012US20120142742 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
06/07/2012US20120142734 Methods for treating tumors with thalidomide
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142668 Cathepsin c inhibitors
06/07/2012US20120142646 Novel Compounds 621
06/07/2012US20120141938 Basic compound, chemically amplified resist composition, and patterning process
06/07/2012US20120138907 Light-emitting device material and light-emitting device
06/07/2012CA2834713A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
06/06/2012EP2460796A1 Indole derivative
06/06/2012EP2460795A1 Fullerene derivatives
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2460793A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors
06/06/2012EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof
06/06/2012EP2460787A1 Amide compounds and their use as PGE2 antagonists.
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 458